Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194,482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group. Flume PA, et al. Among authors: wang x. Lancet Respir Med. 2021 Jul;9(7):733-746. doi: 10.1016/S2213-2600(20)30510-5. Epub 2021 Feb 10. Lancet Respir Med. 2021. PMID: 33581080
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy.
Jen EY, Wang X, Li M, Li H, Lee SL, Ni N, Przepiorka D, Vallejo J, Leong R, Ma L, Gehrke BJ, McLamore S, Theoret MR, de Claro RA. Jen EY, et al. Among authors: wang x. Clin Cancer Res. 2022 Jul 15;28(14):2989-2993. doi: 10.1158/1078-0432.CCR-21-4525. Clin Cancer Res. 2022. PMID: 35325108 Free PMC article. Clinical Trial.
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation.
Woods A, Norsworthy KJ, Wang X, Vallejo J, Chiu Yuen Chow E, Li RJ, Sun J, Charlab R, Jiang X, Pazdur R, Theoret MR, de Claro RA. Woods A, et al. Among authors: wang x. Clin Cancer Res. 2024 Apr 1;30(7):1226-1231. doi: 10.1158/1078-0432.CCR-23-2234. Clin Cancer Res. 2024. PMID: 38010220 Clinical Trial.
Whole-genome resequencing reveals the uniqueness of Subei yak.
Guo S, Wang X, Zhao S, Zhao E, Ainierlitu, Ba T, Gan M, Dong C, Naerlima, Yin L, Ke X, Dana D, Yu T, Guo X. Guo S, et al. Among authors: wang x. J Anim Sci. 2024 Jun 4:skae152. doi: 10.1093/jas/skae152. Online ahead of print. J Anim Sci. 2024. PMID: 38832496
A comparative study of biomechanical assessments in laboratory and field settings for manual material handling tasks using extractor tools and exoskeletons.
Shakourisalim M, Wang X, Beltran Martinez K, Golabchi A, Krell S, Tavakoli M, Rouhani H. Shakourisalim M, et al. Among authors: wang x. Front Bioeng Biotechnol. 2024 May 20;12:1358670. doi: 10.3389/fbioe.2024.1358670. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38832133 Free PMC article.
194,482 results
You have reached the last available page of results. Please see the User Guide for more information.